<DOC>
	<DOC>NCT02425072</DOC>
	<brief_summary>The hypothesis of this study is that the addition of NovoTTF-100A System treatment to salvage chemotherapy will significantly increase time to treatment failure in the brain of small cell lung cancer patients.</brief_summary>
	<brief_title>NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>Histologically confirmed small cell lung cancer histology with CNS metastases Parenchymal disease, ten or less lesions, and supratentorial PS 70% or greater Prior CNS radiotherapy. No previous or currently active second malignancy Age &gt; 22 years. Life expectancy of ≥ 3 months. Significant liver function impairment AST or ALT &gt; 3 times the upper limit of normal; Total bilirubin &gt; upper limit of normal. Significant renal impairment (serum creatinine &gt; 1.7 mg/dL). Coagulopathy (as evidenced by PT or APTT &gt;1.5 times in control patients not undergoing anticoagulation).Thrombocytopenia (platelet count &lt; 100 x 103/μL). Neutropenia (absolute neutrophil count &lt; 1 x 103/μL). Anemia (Hb &lt; 10 g/L). Severe acute infection. Serious nonhealing wound or ulcer on scalp Significant comorbidities within 4 weeks prior to enrollment. Implanted pacemaker, defibrillator or deep brain stimulator, or documented clinically significant arrhythmias. Active implanted medical device (e.g. deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, pacemakers, defibrillators, and programmable shunts). Skull defect (e.g. missing bone with no replacement). Shunt Bullet fragments Evidence of increased intracranial pressure (midline shift &gt; 5mm, clinically significant papilledema, vomiting and nausea or reduced level of consciousness). Sensitivity to conductive hydrogels. Pregnant or lactating women</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Brain</keyword>
	<keyword>Lung</keyword>
	<keyword>Small-cell</keyword>
</DOC>